Elmus Pharmaceuticals Private Limited
About Elmus Pharmaceuticals Private Limited
Data last updated:
Elmus Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 12 March 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2016PTC103852. Its GSTIN is 36AAECE2229G2ZV (Telangana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Syed Azeem Uddin and Mohammed Ibrahim Ahmed.
Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at 5 – 7 – 539 Beside Ap Lodge Nampally, Hyderabad, Telangana, India – 500001.
As per the financials filed for FY 2019, the company reported a revenue of ₹2.19 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹49,683 (net margin -22.7%) and EBITDA of -₹48,886 (EBITDA margin -22.3%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Elmus Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address5 – 7 – 539 Beside Ap Lodge Nampally, Hyderabad, Telangana, India – 500001
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
To see the full contact details of Elmus Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Elmus Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Elmus Pharmaceuticals Private Limited, buy the company report.
Financials of Elmus Pharmaceuticals Private Limited
FY 2019 filings availableElmus Pharmaceuticals Private Limited reported revenue of ₹2.19 Lakh (up 2090% YoY) for FY 2019.
Financial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹48,886 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹49,683 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -22.3% | |||
| Net Profit Margin | -22.7% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Elmus Pharmaceuticals Private Limited, buy the company report.
Board of directors of Elmus Pharmaceuticals Private Limited
Elmus Pharmaceuticals has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Syed Azeem Uddin Also directs: Curovant Pharma Private Limited | Director | 30 Oct 2018 | 8 Years 0 Months | Current |
| Mohammed Ibrahim Ahmed Also directs: Ilv Foundation | Director | 09 Jul 2020 | 6 Years 3 Months | Current |
| Mohammed Mohi Uddin Ahmed | Director | 09 Jul 2020 | 6 Years 3 Months | Current |
Peer comparison
Elmus Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Seawell Pharmaceuticals Private Limited | ₹2.23 Lakh (FY 2019) | Karnal, Haryana, India | ||||
| Ryanscot Pharmaceuticals Private Limited | ₹2.2 Lakh (FY 2023) | Mumbai, Maharashtra, India | ||||
| Apricus Pharmaceuticals Private Limited | ₹2.19 Lakh (FY 2021) | Neemrana, Rajasthan, India | ||||
| Elmus Pharmaceuticals Private Limitedthis company | ₹2.19 Lakh (FY 2019) | -₹49,683 | -22.7% | 2090.0% | Hyderabad, Telangana, India | |
| Nevariss Pharmaceuticals Private Limited | ₹2.17 Lakh (FY 2025) | -60.0% | Delhi, India | |||
| Dermatrait Pharmaceuticals Private Limited | ₹2.17 Lakh (FY 2025) | -7.0% | Delhi, India |
To see the full peer comparison of Elmus Pharmaceuticals Private Limited, buy the company report.
Auditor
Elmus Pharmaceuticals Private Limited is audited by MGR & CO for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MGR & CO | FY 2017 | 012787S |
Shareholding
The shareholding of Elmus Pharmaceuticals Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Elmus Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Elmus Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Elmus Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Elmus Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAECE2229G2ZV | Telangana | Active | 01 Nov 2018 |
To see the full GST registrations and return filing status of Elmus Pharmaceuticals Private Limited, buy the company report.
Recent activity
Elmus Pharmaceuticals Private Limited has 8 board changes on record since 2017: 3 appointments and 5 cessations. The latest: Mohammed Abdul Saleem ceased to be Director on 10 Jul 2020.
Frequently asked questions
Elmus Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in chemical products, within the chemicals industry. It was incorporated on 12 March 2016 (10+ years old) and is registered under CIN U24232TG2016PTC103852.
Elmus Pharmaceuticals has 3 current directors:
- Syed Azeem Uddin - Director
- Mohammed Ibrahim Ahmed - Director
- Mohammed Mohi Uddin Ahmed - Director
The latest financial statements of Elmus Pharmaceuticals on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 30 September 2019. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Elmus Pharmaceuticals is 36AAECE2229G2ZV, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Elmus Pharmaceuticals is U24232TG2016PTC103852. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Elmus Pharmaceuticals was incorporated on 12 March 2016, making it 10+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Elmus Pharmaceuticals by revenue are Seawell Pharmaceuticals Private Limited, Ryanscot Pharmaceuticals Private Limited, Apricus Pharmaceuticals Private Limited, Nevariss Pharmaceuticals Private Limited, Dermatrait Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Mohammed Abdul Saleem ceased to be Director on 10 Jul 2020. Mohammed Salman Uddin ceased to be Director on 10 Jul 2020. Mohd Yousuf Khan ceased to be Director on 10 Jul 2020. Elmus Pharmaceuticals has 8 board changes on record in total.
The registered office of Elmus Pharmaceuticals is at 5 – 7 – 539 Beside Ap Lodge Nampally, Hyderabad, Telangana, India – 500001.
Elmus Pharmaceuticals operates in the chemicals industry, in the chemical products segment.
The compliance status of Elmus Pharmaceuticals is compliant as of 10 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
